These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17320450)

  • 1. Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects.
    Derosa G; D'Angelo A; Tinelli C; Devangelio E; Consoli A; Miccoli R; Penno G; Del Prato S; Paniga S; Cicero AF
    Diabetes Metab; 2007 Apr; 33(2):129-34. PubMed ID: 17320450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.
    Derosa G; D'Angelo A; Scalise F; Avanzini MA; Tinelli C; Peros E; Fogari E; Cicero AF
    Heart Vessels; 2007 Nov; 22(6):361-70. PubMed ID: 18043992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes.
    Derosa G; Cicero AF; Scalise F; Avanzini MA; Tinelli C; Piccinni MN; Peros E; Geroldi D; Fogari E; D'Angelo A
    Endothelium; 2007; 14(1):45-51. PubMed ID: 17364896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia.
    Derosa G; Maffioli P; D'Angelo A; Salvadeo SA; Ferrari I; Fogari E; Gravina A; Mereu R; Palumbo I; Randazzo S; Cicero AF
    Clin Invest Med; 2009 Apr; 32(2):E124-32. PubMed ID: 19331801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-2 and -9 levels in obese patients.
    Derosa G; Ferrari I; D'Angelo A; Tinelli C; Salvadeo SA; Ciccarelli L; Piccinni MN; Gravina A; Ramondetti F; Maffioli P; Cicero AF
    Endothelium; 2008; 15(4):219-24. PubMed ID: 18663625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 diabetes.
    Lee SW; Song KE; Shin DS; Ahn SM; Ha ES; Kim DJ; Nam MS; Lee KW
    Diabetes Res Clin Pract; 2005 Aug; 69(2):175-9. PubMed ID: 16005367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise ameliorates serum MMP-9 and TIMP-2 levels in patients with type 2 diabetes.
    Kadoglou NP; Vrabas IS; Sailer N; Kapelouzou A; Fotiadis G; Noussios G; Karayannacos PE; Angelopoulou N
    Diabetes Metab; 2010 Apr; 36(2):144-51. PubMed ID: 20149706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
    Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
    J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 levels in children and adolescents with type 1 diabetes].
    Florys B; Głowińska B; Urban M; Peczyńska J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):184-9. PubMed ID: 17020653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function.
    Kosmala W; Plaksej R; Przewlocka-Kosmala M; Kuliczkowska-Plaksej J; Bednarek-Tupikowska G; Mazurek W
    Int J Obes (Lond); 2008 May; 32(5):763-71. PubMed ID: 18197181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension.
    Derosa G; D'Angelo A; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo S; Montagna L; Gravina A; Ferrari I; Galli S; Paniga S; Tinelli C; Cicero AF
    Endothelium; 2006; 13(3):227-31. PubMed ID: 16840178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
    Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H
    ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors in women with glucose intolerance in pregnancy and normal controls.
    Stojanovic N; Lewandowski K; Salata I; Bienkiewicz M; Tuck S; Prelevic G; Press M
    Gynecol Endocrinol; 2010 Mar; 26(3):201-7. PubMed ID: 19526397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gelatinases and their tissue inhibitors in a group of subjects with metabolic syndrome.
    Hopps E; Lo Presti R; Montana M; Noto D; Averna MR; Caimi G
    J Investig Med; 2013 Aug; 61(6):978-83. PubMed ID: 23661104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreases in plasma MMP-2/TIMP-2 and MMP-9/TIMP-1 ratios in uremic patients during hemodialysis.
    Lu LC; Yang CW; Hsieh WY; Chuang WH; Lin YC; Lin CS
    Clin Exp Nephrol; 2016 Dec; 20(6):934-942. PubMed ID: 26711243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Matrix Metalloproteinase-2 (MMP-2) and -9 (MMP-9) and Their Tissue Inhibitors (TIMP-1 and TIMP-2) in Plasma from Patients with Neurodegenerative Dementia.
    Tuna G; Yener GG; Oktay G; İşlekel GH; Kİrkalİ FG
    J Alzheimers Dis; 2018; 66(3):1265-1273. PubMed ID: 30412498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
    Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
    Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma levels of TIMP-1 correlate with plasma suPAR/uPA in patients with chronic myeloproliferative disorders.
    Jensen MK; Holten-Andersen MN; Riisbro R; de Nully Brown P; Larsen MB; Kjeldsen L; Heickendorff L; Brünner N; Hasselbalch HC
    Eur J Haematol; 2003 Nov; 71(5):377-84. PubMed ID: 14667201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes.
    Maxwell PR; Timms PM; Chandran S; Gordon D
    Diabet Med; 2001 Oct; 18(10):777-80. PubMed ID: 11678966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months.
    Derosa G; Cicero AF; Scalise F; Avanzini MA; Tinelli C; Peros E; Fogari E; D'Angelo A
    Endothelium; 2007; 14(4-5):175-83. PubMed ID: 17922333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.